Why Is Plasma Renin Activity Lower in Populations of African Origin?
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Cardiovascular System 9
Chapter Cardiovascular System 9 Learning Outcomes On completion of this chapter, you will be able to: 1. State the description and primary functions of the organs/structures of the car- diovascular system. 2. Explain the circulation of blood through the chambers of the heart. 3. Identify and locate the commonly used sites for taking a pulse. 4. Explain blood pressure. 5. Recognize terminology included in the ICD-10-CM. 6. Analyze, build, spell, and pronounce medical words. 7. Comprehend the drugs highlighted in this chapter. 8. Describe diagnostic and laboratory tests related to the cardiovascular system. 9. Identify and define selected abbreviations. 10. Apply your acquired knowledge of medical terms by successfully completing the Practical Application exercise. 255 Anatomy and Physiology The cardiovascular (CV) system, also called the circulatory system, circulates blood to all parts of the body by the action of the heart. This process provides the body’s cells with oxygen and nutritive ele- ments and removes waste materials and carbon dioxide. The heart, a muscular pump, is the central organ of the system. It beats approximately 100,000 times each day, pumping roughly 8,000 liters of blood, enough to fill about 8,500 quart-sized milk cartons. Arteries, veins, and capillaries comprise the network of vessels that transport blood (fluid consisting of blood cells and plasma) throughout the body. Blood flows through the heart, to the lungs, back to the heart, and on to the various body parts. Table 9.1 provides an at-a-glance look at the cardiovascular system. Figure 9.1 shows a schematic overview of the cardiovascular system. -
Aldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship
Journal of Endocrinology and Thyroid Research ISSN: 2573-2188 Review Article J Endocrinol Thyroid Res Volume 4 Issue 3 - May 2019 Copyright © All rights are reserved by Vismay Naik DOI: 10.19080/JETR.2019.04.555637 Aldosterone and Parathyroid Hormone: Evidence for a Clinically Relevant Relationship Vismay Naik* PG Diploma in Endocrinology and Diabetes, Ashirvad Heart and Diabetes Centre, India Submission: April 13, 2019; Published: May 06, 2019 *Corresponding author: Vismay Naik, MD, MRCP(UK), PG Diploma in Endocrinology and Diabetes, Ashirvad Heart and Diabetes Centre, India Introduction hyperparathyroidism due to increased renal and faecal calcium A ‘new endocrine axis’, involving the bi-directional relati- excretion. PTH is increased as a result of the MR (mineralocorticoid onship between the parathyroid hormone (PTH) and the renin– receptor) mediated calciuretic and magnesiuretic effects, with a angiotensin–aldosterone system (RAAS) has been established trend towards hypocalcemia, hypomagnesemia and the direct recently. Individually these have long been recognized, althou- effects of aldosterone on parathyroid cells via binding to the MR. gh it is only in recent times that we are realizing the interplay Moreover, the angiotensin II receptor is expressed by human between the two and the corresponding effects this has on the parathyroid tissue, and angiotensin may therefore directly physiological and pathological roles within the body. Other cal- stimulate PTH secretion [6]. ciotropic hormones such as Vitamin D are also impacting on this relationship [1]. This report aims to highlight the cyclic nature of RAAS and Vitamin D these relationships, through the physiological pathways, which Aldosterone acts through the mineralocorticoid receptor, will then lead into pathological disease in multiple areas such as which belongs to the same superfamily of nuclear receptors as heart failure, cardiovascular health and bone homeostasis. -
Hypertension: Shall We Focus on Adipose Tissue?
www.jasn.org EDITORIALS Hypertension: Shall We Focus associated with incident hypertension among women with- out diabetes. The authors prospectively studied 872 women on Adipose Tissue? without diabetes or hypertension from the Nurses’ Health Study. After a follow-up of 14 years, 361 (41.4%) women Simona Bo and Paolo Cavallo-Perin developed hypertension. Plasma resistin values were signif- Department of Internal Medicine, University of Turin, Turin, Italy icantly associated with incident hypertension: The highest resistin tertile conferred a 75% higher risk for hypertension J Am Soc Nephrol 21: 1067–1068, 2010. doi: 10.1681/ASN.2010050524 than the lowest (relative risk 1.75; 95% confidence interval 1.19 to 2.56). The relative risk did not substantially change after adjustment for multiple potential metabolic and nu- Adipose tissue is an active endocrine organ that produces sub- tritional confounding factors and for other adipokines. The stances having local and systemic actions on blood vessels, kid- risk was greater among older women. In a secondary analy- neys, and the heart. Leptin, adiponectin, resistin, angiotensin sis, inflammatory and endothelial biomarkers were mea- ␣ II, adipsin, TNF- , IGF-1, plasminogen-activator inhibitor 1, sured in a subset of women. Resistin levels were significantly and prostaglandins compose an incomplete list.1 associated with both groups of biomarkers. After further Resistin, an adipokine belonging to the cysteine-rich secre- adjustment for C-reactive protein, IL-6, soluble TNF recep- tory protein family, was described as an adipocyte-derived tor 2, intercellular adhesion molecule 1, vascular adhesion polypeptide that links obesity and insulin resistance in mice2; molecule 1, and E-selectin, resistin concentrations re- however, striking differences in the genomic organization and mained positively associated with an increased risk for inci- cellular source of resistin in rodents versus humans and the dent hypertension. -
Blood and Lymph Vascular Systems
BLOOD AND LYMPH VASCULAR SYSTEMS BLOOD TRANSFUSIONS Objectives Functions of vessels Layers in vascular walls Classification of vessels Components of vascular walls Control of blood flow in microvasculature Variation in microvasculature Blood barriers Lymphatic system Introduction Multicellular Organisms Need 3 Mechanisms --------------------------------------------------------------- 1. Distribute oxygen, nutrients, and hormones CARDIOVASCULAR SYSTEM 2. Collect waste 3. Transport waste to excretory organs CARDIOVASCULAR SYSTEM Cardiovascular System Component function Heart - Produce blood pressure (systole) Elastic arteries - Conduct blood and maintain pressure during diastole Muscular arteries - Distribute blood, maintain pressure Arterioles - Peripheral resistance and distribute blood Capillaries - Exchange nutrients and waste Venules - Collect blood from capillaries (Edema) Veins - Transmit blood to large veins Reservoir Larger veins - receive lymph and return blood to Heart, blood reservoir Cardiovascular System Heart produces blood pressure (systole) ARTERIOLES – PERIPHERAL RESISTANCE Vessels are structurally adapted to physical and metabolic requirements. Vessels are structurally adapted to physical and metabolic requirements. Cardiovascular System Elastic arteries- conduct blood and maintain pressure during diastole Cardiovascular System Muscular Arteries - distribute blood, maintain pressure Arterioles - peripheral resistance and distribute blood Capillaries - exchange nutrients and waste Venules - collect blood from capillaries -
High and Non-Suppressible Plasma Renin Activity in a Patient with Aldosterone Producing Adenoma: Pathophysiologic and Diagnostic Implications
Journal of Human Hypertension (1999) 13, 75–78 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh CASE REPORT High and non-suppressible plasma renin activity in a patient with aldosterone producing adenoma: pathophysiologic and diagnostic implications E Shyong Tai and PHK Eng Department of Endocrinology, Singapore General Hospital, Singapore We describe a case of primary aldosteronism due to an possible pathophysiological causes of a rise in PRA in aldosterone producing adenoma with high and non-sup- this clinical setting and suggest that underlying arteri- pressible plasma renin activity (PRA). She had sup- olar disease due to prolonged hypertension may be the pressed PRA at initial diagnosis. This rose above the cause of increased and non-suppressible PRA in pri- reference range for normal individuals over a period of mary aldosteronism. 7 years with untreated hypertension. We discuss the Keywords: primary aldosteronism; plasma renin activity; diagnosis Introduction Case report Primary aldosteronism is classically associated with Our patient was a 34-year-old woman who was hypertension, hypokalaemia and suppressed plasma found to have hypertension during the fifteenth renin activity (PRA). Most cases are due to an aldo- week of pregnancy. Plasma aldosterone was sterone producing adenoma (APA). We present a 2039 pmol/l, PRA Ͻ0.15 g/l/h and a diagnosis of case of prolonged, untreated, primary aldosteronism primary aldosteronism was made. Following the due to an APA. She had suppressed PRA at the time delivery of her child, she defaulted follow-up and of diagnosis, which became elevated and non-sup- was not treated with any antihypertensives nor pot- pressible by intravenous salt loading. -
Cardiovascular System Summary Notes the Cardiovascular System
Cardiovascular System Summary Notes The cardiovascular system includes: The heart, a muscular pump The blood, a fluid connective tissue The blood vessels, arteries, veins and capillaries Blood flows away from the heart in arteries, to the capillaries and back to the heart in the veins There is a decrease in blood pressure as the blood travels away from the heart Arterial branches of the aorta supply oxygenated blood to all parts of the body Deoxygenated blood leaves the organs in veins Veins unite to form the vena cava which returns the blood to the heart Pulmonary System This is the route by which blood is circulated from the heart to the lungs and back to the heart again The pulmonary system is exceptional in that the pulmonary artery carries deoxygenated blood and the pulmonary vein carries oxygenated blood Hepatic Portal Vein There is another exception in the circulatory system – the hepatic portal vein Veins normally carry blood from an organ back to the heart The hepatic portal vein carries blood from the capillary bed of the intestine to the capillary bed of the liver As a result, the liver has three blood vessels associated with it Arteries and Veins The central cavity of a blood vessel is called the lumen The lumen is lined with a thin layer of cells called the endothelium The composition of the vessel wall surrounding the endothelium is different in arteries, veins and capillaries Arteries carry blood away from the heart Arteries have a thick middle layer of smooth muscle They have an inner and outer layer of elastic fibres Elastic -
Aldosterone-Renin Ratio (Arr)
RENIN -ALDOSTERONE PROFILING: ALDOSTERONE-RENIN RATIO (ARR) 1. Obtain a morning specimen for serum aldosterone (redtop tube) and plasma renin (lavender-top) tube from an upright patient sitting for a period of 15 min prior to (being seated for) blood drawing. Fasting is not required and no salt restriction is necessary. 2. Spironolactone. The ratio cannot be assessed in patients receiving spironlactone. If primary aldosteronism (PA) is suspected in a patient receiving this drug, treatment should be discontinued for 4-6 weeks (1). 3. Hypokalemia should be corrected before ARR is measured as a low K will lower aldosterone and can lead to a falsely negative ARR (1). 4. Preferred antihypertensives that have a minimal effect on the ARR are doxazozin (Cardura), prazosin (Minipress), verapramil slow release, or hydralazine, singly or in combination for one month before sampling (1). 5. False-positive ARR: Beta-blockers, clonidine, methyldopa, and NSAID’s lower levels of renin and can cause a falsely positive ARR (1). A minimum 3-day cessation prior to sampling is recommended (3). The renin direct assay is also lower in patients on oral contraceptives and hormone replacement therapy potentially causing the ARR to be falsely increased. Measurement of plasma renin activity is preferred in this situation, calculating the aldosterone/PRA ratio (positive if >20/1). 6. False-negative ARR: Diuretics cause false negatives by causing K loss lowering aldosterone and stimulating renin through volume loss. Angiotensin blockers (ARB’s), ACE inhibitors, and some calcium channel blockers raise renin and can cause false negatives (1). A minimum three-day cessation prior to sampling is recommended (3). -
The Renin-Angiotensin System and the Heart: a Historical Review Heart: First Published As 10.1136/Hrt.76.3 Suppl 3.7 on 1 November 1996
Heart (Supplement 3) 1996;76:7-12 7 The renin-angiotensin system and the heart: a historical review Heart: first published as 10.1136/hrt.76.3_Suppl_3.7 on 1 November 1996. Downloaded from Stephen J Cleland, John L Reid Early observations on a possible link effect but was in fact an enzyme. The names between the kidney and the "hypertensin""l and "angiotonin"12 were given cardiovascular system to the pressor substance formed from the renin In 1836 an English clinician Richard Bright substrate by the enzymatic action of renin. observed that patients dying with contracted Subsequently, it was agreed that the term kidneys often had a hard, full pulse and cardiac "angiotensin" would be used to describe this hypertrophy.' In 1889 Brown-Sequard, the substance. During this period the potential for "father" of endocrinology, showed that injec- pathological effects of renin was recognised. tions of extracts from guinea pig testicles were Winternitz described necrotising arteriolar able to produce systemic effects of vigour and lesions in animals which had undergone renal the perception of rejuvenation.2 On this back- artery ligation and also in nephrectomised ani- ground, in 1896 the Finnish physiologist mals which had been given kidney extracts.'3 Robert Tigerstedt and his student Per Finally, the relevance of renal control of blood Bergman began to explore the possibility that pressure in man was described by Young who, kidney extracts from rabbits may have some in 1936, cured a case of malignant hyperten- systemic effects on the cardiovascular system. sion by removing an ischaemic kidney.'4 In 1898 their classic paper was published showing that intravenous injection of these renal extracts exerted a pressor effect. -
SGLT2 Inhibition and Potential Renal Protection
The knowns and unknowns of SGLT2 inhibition in CKD Paola Fioretto, MD Padua, Italy June 14, 2019 - Budapest, Hungary SGLT2 inhibition in CKD: Discussing the key questions and evidence Budapest, june 14 2019 The knowns and unknowns of SGLT2 inhibition in CKD Paola Fioretto Department of Medicine University of Padova, Italy 180 g of glucose filtered Glomerulus Proximal tubule Distal tubule Collecting duct each day S1 S2 Glucose filtration S3 SGLT2 SGLT1 90% 10% Glucose reabsorption Loop of Henle Up to ~ 90% of glucose ~ 10% of glucose Minimal is reabsorbed is reabsorbed glucose from the S1/S2 segments from the S3 segment excretion Possible mechanisms responsible for cardiovascular and renal protection with SGLT2 inhibition SGLT2 inhibition Glycosuria Natriuresis ↓Blood ↓Plasma Negative caloric balance ↑Uricosuria pressure ↑Tubuloglomerular volume feedback ↓Myocardial ↓HbA1c ↓ Afferent stretch ↓ ↓Plasma uric ↓Arterial ↓ arteriole acid stiffness ↑ constriction ↓Total body fat mass ↓Inflammation ↓Glucose toxicity ↓Epicardial fat ↓Intraglomerular hypertension ↓Ventricular ↓Hyperfiltration arrhythmias ↓Atherosclerosis Activation of ACE2 – Ang1/7 ↑Cardiac contractility ↓Inflammation No sympathetic nervous system activation ↓Fibrosis Cardiac and renal protection Heerspink HJ et al, Circulation 2016 Tonneijck et al, J Am Soc Nephrol 2017 Diabetic nephron Diabetic nephron with SGLT2 i Effects of SGLT2 i on afferent arteriole tone: in vivo studies with multiphoton microscope imaging techniques Kidokoro K et al, Circulation 2019 Effects of SGLT2 i -
Plasma Renin Activity and Pro-B-Type Natriuretic Peptide Levels in Different Atrial Fibrillation Types
Original Investigation Özgün Araşt›rma 317 Plasma renin activity and pro-B-type natriuretic peptide levels in different atrial fibrillation types Farklı atriyal fibrilasyon türlerinde plazma renin aktivitesi ve pro-B-tipi natriüretik peptit düzeyleri Abdullah Doğan, Ömer Gedikli1, Mehmet Özaydın, Gürkan Acar2 Department of Cardiology, Faculty of Medicine, Süleyman Demirel University, Isparta 1Department of Cardiology, Faculty of Medicine, Karadeniz Technical University, Trabzon 2Department of Cardiology, Faculty of Medicine, Sütçü Imam University, Kahramanmaraş, Turkey ABSTRACT Objective: Renin-angiotensin system may be activated during atrial fibrillation (AF). Our aim was to evaluate plasma renin activity (PRA) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients with different AF types who had normal left ventricular (LV) systolic function. Methods: This cross-sectional study included 97 patients with recent (≤7 days), persistent (7 days to 12 months) and permanent AF (>12 months), and age- and sex-matched 30 controls with sinus rhythm. Plasma levels of PRA and NT-pro-BNP were measured and presented as median (25th-75th percentiles). Echocardiographic examination was performed in all population. Variance and logistic regression analyses were also used for multiple comparisons and independent predictors, respectively. Results: Median NT-proBNP levels were higher in overall patients with AF than in controls [114 (63-165) vs 50 (38-58) pg/ml, p<0.001), but PRA level was comparable in both groups. Similarly, NT-proBNP levels were also higher in all subtypes of AF compared with controls (p<0.05). In addition, there was a significant difference in NT-proBNP level among recent, persistent and permanent AF subtypes (p=0.001). -
Effects of Moxonidine on the Sympathetic Nervous System
Journal of Clinical and Basic Cardiology An Independent International Scientific Journal Journal of Clinical and Basic Cardiology 2004; 7 (1-4), 19-25 Effects of Moxonidine on the Sympathetic Nervous System, Blood Pressure, Plasma Renin Activity, Plasma Aldosterone, Leptin, and Metabolic Profile in Obese Hypertensive Patients Sanjuliani AF, Francischetti EA, Genelhu de Abreu V Ueleres Braga J Homepage: www.kup.at/jcbc Online Data Base Search for Authors and Keywords Indexed in Chemical Abstracts EMBASE/Excerpta Medica Krause & Pachernegg GmbH · VERLAG für MEDIZIN und WIRTSCHAFT · A-3003 Gablitz/Austria ORIGINAL PAPERS, CLINICAL CARDIOLOGY Moxonidine in Obese Hypertensive Patients J Clin Basic Cardiol 2004; 7: 19 Effects of Moxonidine on the Sympathetic Nervous System, Blood Pressure, Plasma Renin Activity, Plasma Aldosterone, Leptin, and Metabolic Profile in Obese Hypertensive Patients A. F. Sanjuliani, V. Genelhu de Abreu, J. Ueleres Braga, E. A. Francischetti Obesity accounts for around 70 % of the patients with primary hypertension. This association accentuates the risk of cardiovascular disease as it is frequently accompanied by the components of the metabolic syndrome. Clinical, epidemiological and experimental studies show an association between obesity-hypertension with insulin resistance and increased sympathetic nervous system activity. We conducted the present study to evaluate in forty obese hypertensives of both genders, aged 27 to 63 years old, the chronic effects of moxonidine – a selective imidazoline receptor agonist – on blood pressure, plasma catecholamines, leptin, renin-angiotensin aldosterone system and components of the metabolic syndrome. It was a randomized parallel open study, amlodipine was used as the control drug. Our results show that moxonidine and amlodipine significantly reduced blood pressure without affecting heart rate when measured by the oscillometric method and with twenty-four-hour blood pressure monitoring. -
Blood Vessels and Circulation
19 Blood Vessels and Circulation Lecture Presentation by Lori Garrett © 2018 Pearson Education, Inc. Section 1: Functional Anatomy of Blood Vessels Learning Outcomes 19.1 Distinguish between the pulmonary and systemic circuits, and identify afferent and efferent blood vessels. 19.2 Distinguish among the types of blood vessels on the basis of their structure and function. 19.3 Describe the structures of capillaries and their functions in the exchange of dissolved materials between blood and interstitial fluid. 19.4 Describe the venous system, and indicate the distribution of blood within the cardiovascular system. © 2018 Pearson Education, Inc. Module 19.1: The heart pumps blood, in sequence, through the arteries, capillaries, and veins of the pulmonary and systemic circuits Blood vessels . Blood vessels conduct blood between the heart and peripheral tissues . Arteries (carry blood away from the heart) • Also called efferent vessels . Veins (carry blood to the heart) • Also called afferent vessels . Capillaries (exchange substances between blood and tissues) • Interconnect smallest arteries and smallest veins © 2018 Pearson Education, Inc. Module 19.1: Blood vessels and circuits Two circuits 1. Pulmonary circuit • To and from gas exchange surfaces in the lungs 2. Systemic circuit • To and from rest of body © 2018 Pearson Education, Inc. Module 19.1: Blood vessels and circuits Circulation pathway through circuits 1. Right atrium (entry chamber) • Collects blood from systemic circuit • To right ventricle to pulmonary circuit 2. Pulmonary circuit • Pulmonary arteries to pulmonary capillaries to pulmonary veins © 2018 Pearson Education, Inc. Module 19.1: Blood vessels and circuits Circulation pathway through circuits (continued) 3. Left atrium • Receives blood from pulmonary circuit • To left ventricle to systemic circuit 4.